INTRODUCTION
Mucosal surfaces are constantly exposed to microorganisms and represent the main portal of entry of pathogens and toxins. Mucosal immunoglobulin-A (IgA) or secretory IgA (SIgA) neutralizes pathogenic microorganisms and toxins, interferes with bacterial or viral colonization of the epithelium, and participates in homeostasis of mucosal tissues. 1 Ideally, vaccines capable of promoting both IgG in the bloodstream and SIgA in mucosal tissues would provide two layers of defense for optimal protection against infectious agents. Injected vaccines containing alum, the most widely used adjuvant, induce serum IgG responses, but unlike experimental mucosal adjuvants, fails to promote SIgA responses. 2, 3 Cholera toxin (CT) and the related heat labile toxin (LT) I of Escherichia coli are the most studied experimental adjuvants for induction of SIgA, 4 however, their inherent toxicity precludes their use in oral or nasal vaccines.
Cytokines play a crucial role in shaping the profile of T-helper (Th) cytokine responses as well as the Ig isotype and subclass responses. Previous studies have shown that the mucosal adjuvant CT induces pro-inflammatory cytokine (i.e., interleukin-6 (IL-6) or IL-1b) secretion by antigen-presenting cells (i.e., macrophages and dendritic cells). 5, 6 CT also induces transforming growth factor beta (TGF-b) and IL-10, two antiinflammatory cytokines that play a central role in the induction of SIgA. [6] [7] [8] Studies with live bacterial and viral vectors as well as immunization studies with Th1-inducing cytokines (i.e., IL-12 and IL-18) have now established that SIgA can also be induced in the context of Th1-biased responses. 4 More recently, the ability of CT as an adjuvant to promote SIgA responses was shown to be impaired in mice lacking IL-17A, suggesting a role for IL-17A or related signaling in SIgA responses. 6 In this regard, differentiation of Th17 cells requires IL-1b, IL-6, and TGFb, 6, 9 which are cytokines that support IgA responses. Unlike Th1 and Th2 cytokines, which activate JAK-STAT signaling pathways, signaling through IL-17R activates Act1 for subsequent activation of the classical nuclear factor kB (NF-kB) signaling pathway. 10 Furthermore, IL-17A directly triggers Ig class switching to IgG2a and IgG3, but not to IgG1. 11 To our knowledge, it is still unclear whether production of IgA is directly regulated by IL-17A/IL-17RA signaling in B cells.
The NF-kB pathway plays an important role in inflammatory responses and a number of stimuli can lead to NF-kB translocation to the nucleus. 12 Previous studies have shown that the NF-kB pathway can mediate both pro-and anti-inflammatory effects 13, 14 depending on the immune cells in which the IKKb-NF-kB signaling occurs 15 and stimuli to which they are exposed. A recent study showed a link between activation of the non-canonical NF-kB pathway in B cells and their ability to undergo immunoglobulin class switch for the production of IgA. 16 However, it remains unclear if IKKb-dependent signaling in myeloid cells regulates IgA responses to mucosal vaccination.
Sublingual tissues have been used as a delivery site for bacterial and viral vaccines, 17, 18 and cervical lymph nodes (CLNs) were identified as the primary site of antigen presentation after sublingual immunization. 19 However, how innate immune cells in sublingual tissues and/or CLNs regulate antibody production remains unknown. Edema toxin (EdTx) is one of the exotoxins produced by the Gram-positive, sporeforming rod Bacillus anthracis. 20 EdTx is composed of two subunits: a binding subunit and an enzymatic subunit. The binding subunit, or protective Ag (PA), allows the binding of these toxins to the anthrax toxin receptors that are expressed by most cells. The enzymatic subunit, or edema factor, is a calmodulin-and calcium-dependent adenylate cyclase that catalyzes the conversion of ATP to cyclic AMP. 20, 21 We previously showed that EdTx is a mucosal adjuvant that promotes mucosal and systemic immunity to intranasally co-administered vaccine antigens. 22, 23 Here we addressed the contribution of monocytes/macrophages to mucosal SIgA responses after sublingual immunization. Using B. anthracis EdTx as a model of vaccine adjuvant to target anthrax toxin receptors, we show a previously unknown role of neutrophils as negative regulators of IgA responses. Thus, recruitment of neutrophils into sublingual tissues and CLNs shortly after sublingual immunization impaired the development of IgA responses. The negative role of neutrophils in IgA responses was confirmed in vivo by depletion of neutrophils before immunization with EdTx and in vitro by co-culture of B cells with neutrophils.
RESULTS

Toxin adjuvants differentially recruit myeloid-lineage cells into sublingual tissues
Both CT 24 and EdTx 22, 23 are mucosal adjuvants that promote mucosal SIgA responses via the nasal route. CT can also promote IgA responses when used as an adjuvant for vaccines given by the epicutaneous route or topically on the sublingual mucosa. 19, 25 In contrast, EdTx was not effective at inducing IgA when used as an epicutaneous (Duverger et al., unpublished observation) or sublingual adjuvant. To elucidate the mechanism underlying the inability of EdTx to induce IgA by the sublingual route, we first analyzed innate cell subsets present in sublingual tissues after sublingual application of EdTx. The number of CD11b þ myeloid cells increased in the sublingual tissues of mice 3 h after application of EdTx, but not CT (Figure 1a) . Flow cytometric 26 and morphologic analysis of the myeloid cell subsets (Supplementary Figures S1B-D (Figure 1c,d ).
EdTx does not recruit neutrophils into sublingual tissues of mice lacking IKKb in myeloid cells
The adjuvant activities of CT and EdTx involve pro-inflammatory responses and acquisition of antigen-presenting cell functions by myeloid cells. 22, 23, [27] [28] The transcription factor NF-kB is a master regulator of cytokine responses and migration of innate cells. 29 We previously showed that activation of NF-kB in mouse epithelial cells lacking IKKb and with impaired ability for nuclear translocation of phospoNF-kB p65, resulted in increased pSTAT3 responses in gut tissues. 30 Thus, we examined how EdTx affects the expression of STAT3 in sublingual tissues of control and IKKb DMye mice, which lack IKKb in myeloid cells. As depicted in Figure 2a and Supplementary Figure S2 , pSTAT3 levels were low in tissues of mice that received saline and increased after application of EdTx. In contrast, pNF-kB levels were higher in tissues of phosphatebuffered saline-than in EdTx-treated mice. Although the transcription factors appeared to be regulated in the opposite direction after EdTx-treatment, the difference in their levels of expression failed to reach statistical significance during the time frame analyzed (Figure 2a and Supplementary Figure S2) .
We also analyzed myeloid cells in sublingual tissues at 3 and 6 h after application of EdTx (Figure 2b ,c and Supplementary Figure S3 ). Unlike control C57BL/6 mice, the IKKb DMye mice did not exhibit an important increase in the frequency of CD11b þ cells in the sublingual tissues 3 h after application of EdTx (Figure 2b) . Control C57BL/6 and IKKb DMye mice exhibited a similar proportion of myeloid cell subsets before application of EdTx, except for non-inflammatory monocytes, which were higher in IKKb DMye than in control C57BL/6 mice ( Figure 2c and Supplementary Figure S3) . Three hours after application of EdTx, sublingual tissues of IKKb DMye mice showed significantly lower frequencies of neutrophils when compared with C57BL/6 ( Figure 2c and Supplementary Figure S3) .
EdTx was reported to differentially affect the recruitment and cytokine secretion by some immune cells. 31 Therefore, we also examined the expression of CCL2 and CXCL2, two chemokines known to recruit inflammatory monocytes and neutrophils, respectively. Sublingual tissue cells of control C57BL/6 and IKKb DMye mice had similar basal levels of CCL2 and CXCL2 messenger RNA (mRNA), and exhibited similar kinetics and magnitude of responses after exposure to EdTx (Supplementary Figure S4) . We also examined the expression of CCR2 and CXCR2, the receptors of CCL2 and CXCL2 by myeloid cell subsets, in sublingual tissues 3 h after application of EdTx in vivo (Figure 3) . Since leukotriene B4 could mediate chemotaxis of macrophages and granulocytes, 32, 33 the expression of the leukotriene B4 receptor (LTB4R2) was also investigated. Neutrophils in sublingual tissues of C57BL/6 and IKKb DMye mice exhibited similar profiles of receptor expression (Figure 3b,c) . On the other hand, macrophages/ DCs and non-inflammatory monocytes collected in sublingual tissues of IKKb DMye mice exhibited higher frequencies of CCR2 þ , CXCR2 þ , and LTB4R2 þ cells. Alone, these results cannot explain the higher number of neutrophils in the sublingual tissues of C57BL/6. The pie diagram (Figure 3c) We also asked whether the specificity and function of antibody (Ab) induced by EdTx as sublingual adjuvant were affected by the absence of IKKb-dependent signaling in myeloid cells. After sublingual immunization with F1-V alone, control C57BL/6 and IKKb DMye mice developed IgG Abs, which were directed against the same peptide (i.e., P 1-17 or P1) of the F1-capsular antigen ( Figure 4c and Table 1 ). EdTx as an adjuvant promoted Abs that reacted to two additional epitope peptides in control C57BL/6 and IKKb DMye mice. However, only one of the additional peptides (P19) was shared by Abs from control C57BL/6 and IKKb DMye mice ( Figure 4c and Table 1) .
We also wondered whether the enhanced IgA responses seen in IKKb DMye mice were restricted to FI-V as antigen and EdTx as adjuvant. Nasal immunization with EdTx is known to promote immunity against the EdTx binding subunit PA. 22, 23 Sublingual immunization with EdTx also enhanced PA-specific serum IgG Ab titers in IKKb DMye mice (Supplementary Figure  S5A) and this was consistent with the enhanced levels of PA-specific neutralizing Abs (Supplementary Figure S5B) . In addition, we found that serum and mucosal IgA responses induced by CT as a sublingual adjuvant were enhanced in IKKb DMye mice (Supplementary Figure S6) . Finally, we analyzed antigen (F1-V)-specific Th cytokine responses supported by EdTx as an adjuvant for sublingual vaccination. In wild-type C57BL/6 mice, the sublingual adjuvant EdTx enhanced the frequency of antigen-specific IFN-g producing Th cells in the spleen ( Figure 5 ). On the other hand, the IKKb DMye mice exhibited a broader profile of Th-cell responses with a significant increase of antigen-specific IFN-g (Th1), IL-4 (Th2), IL-10 þ , and IL-17A þ producing Th cells ( Figure 5 ).
The frequency of neutrophils inversely correlates with production of IgA in CLNs
CLNs are considered inductive sites for adaptive immune responses after sublingual 19 and nasal 34 immunization. We have shown that 6 h after application of EdTx, the frequency of CD11b þ cells returned toward basal levels in sublingual tissues ( Figure 2b) . We hypothesized that cells had migrated to CLN and thus analyzed myeloid cell subsets in these lymphoid tissues. The frequency of neutrophils was significantly reduced in CLNs of IKKb DMye compared to control C57BL/6 mice, while the other myeloid cell subsets remained unchanged (Figure 6a ). CLN cells from EdTx-treated mice were then cultured in the presence of lipopolysaccharide. Three days later, we found a significantly higher number of IgA-secreting cells in IKKb DMye than in control C57BL/6 mice ( Figure 6b) . Of interest, the number of IgA-secreting cells in the CLNs of both control C57BL/6 and IKKb DMye mice were inversely correlated (r ¼ À 0.8) with the numbers of neutrophils in these tissues ( Figure 6c ).
Reduction of neutrophils augments the adjuvant effect of EdTx on Ag-specific IgA responses
To further establish that an inverse correlation exists between the frequency of neutrophils in sublingual tissues and CLNs, and antigen-specific IgA responses, wild-type C57BL/6 were injected (IP) with a neutrophil Ly6G-specific 1A8 monoclonal Ab 2 days before sublingual immunization with F1-V and EdTx as an adjuvant. This treatment reduced the frequency of neutrophils in CLNs of wild-type C57BL/6 mice (Supplementary Figure S7A) , and C57BL/6 mice pre-treated with 1A8 (1A8 þ C57BL/6) contained virtually no neutrophils in sublingual tissues after application of EdTx (Supplementary Figure S7B) . These 1A8 þ C57BL/6 mice also gradually developed F1-V-specific serum IgA titers over the time points tested and reached higher serum IgA titers than non-treated C57BL/6 or IKKb DMye mice at Day 28 ( Figure 6d) . Interestingly, depletion of neutrophils also enhanced mucosal IgA Ab responses; 1A8 þ C57BL/6 mice produced high levels of F1-Vspecific fecal IgA Abs, which were comparable to those measured in IKKb DMye mice (Figure 6d ).
Neutrophils suppress production of IgA by B cells
Our results clearly show that the ability to generate IgA responses is enhanced in the absence of IKKb in myeloid cells or when the number of neutrophils is reduced. In addition, the ability of EdTx to induce systemic and mucosal IgA responses in IKKb DMye mice is associated with increased Th17 responses and production of IL-17A ( Figure 5) 
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saccharide. 35 After 5 days of culture, cells were segregated into IL-17RA low and IL-17RA high cells (Supplementary Figure S8A) .
Co-culture with IKKb
DMye CD11b þ cells significantly increased the frequency of B220
þ IL-17RA high B cells (Supplementary Figure S8B) . As shown in Figure 7a, DMye CD11b þ cells further increased these frequencies. To further elucidate signals that supported IgA responses, we analyzed mRNA levels of the B-cell activators a proliferation-inducing ligand (APRIL) and B-cell activation factor of the TNF family (BAFF), and activation-induced deaminase (AID). Addition of EdTx to cultures of spleen cells enhanced mRNA levels of APRIL, BAFF, and AID, and the presence of IKKb DMye CD11b þ further enhanced BAFF-and AID-specific mRNA expression (Supplementary Figure S8C ). The presence of IKKb DMye CD11b þ did not affect EdTx-induced IL-1b and IL-6 mRNA levels, but increased EdTx-induced TNF-a, IL-23, IL-10, and Caspase-1 mRNA levels (Supplementary Figure S9) . Taken together, these results show that myeloid cells lacking IKKb provide a microenvironment favorable for Ig class switch and B-cell production of IgA.
To gain insight into the mechanism of how neutrophils affect IgA responses, B cells from C57BL/6 mice were co-cultured with or without neutrophils from C57BL/6 or IKKb DMye mice for 5 days. The addition of neutrophils from either C57BL/6 or IKKb DMye mice to cultures of B cells did not affect the secretion of IgM or IgG Abs into culture supernatants (Figure 7b) . Interestingly, co-culture with neutrophils significantly reduced the amounts of IgA Abs secreted by B cells and this inhibitory effect was independent of the presence of functional IKKb in neutrophils (Figure 7b) . Finally, mRNA analysis of B cells cocultured with neutrophils showed that neutrophils reduced the level of IgA heavy chain transcripts in B cells (Figure 7c) .
DISCUSSION
Recent studies have identified sublingual immunization as a potentially safer alternative to nasal immunization. However, inductive sites for generating immune responses to sublingual immunization, the identity and function of the cells involved, and the signaling pathways for induction of SIgA via this mucosal route are poorly understood. Here, we show that the ability of a sublingual vaccine to mount a SIgA response inversely correlates with the presence of neutrophils in sublingual tissue and CLNs. We also show that depletion of
Ly6G
þ cells improves the development of IgA responses after sublingual immunization and that neutrophils impair the transcription of IgA heavy chain in B cells. This work also shows that myeloid cells lacking IKKb-dependent NF-kB signaling provide an environment that supports the production of IgA by B cells.
Alum is the most widely used adjuvant for injected vaccines. However, attempts to include alum in mucosal vaccines aimed at prompting SIgA responses have been unsuccessful because this adjuvant fails to effectively induce IgA. 2 Studies that addressed mechanisms underlying the adjuvant activity of alum have shown that alum acts via Gr-1 splenic myeloid cells expressing IL-4 to stimulate early B-cell priming. 36 Other studies have shown that the NALP3 inflammasome was a crucial element in the adjuvant activity of alum by promoting the maturation of inflammatory cytokines 37 ; and furthermore, alum recruits inflammatory monocytes. 38 In other studies, intranasal co-administration of human neutrophil proteins enhanced antigen-specific serum IgG responses, but failed to promote SIgA responses. 39 These reports are consistent with our finding that less recruitment of neutrophils into sublingual tissues and CLNs of IKKb DMye mice is a reliable indication of the ability of EdTx as an adjuvant to promote SIgA responses. Because IgG production is not impaired by the recruitment of neutrophils, it is unlikely that neutrophils limit SIgA responses by limiting antigen access to antigen-presenting cells or interactions between the latter and T cells as was previously suggested. 40 Induction of SIgA is well-known to require priming of effector cells in unique inductive sites. 4 Thus, our finding, that the low proportion of Gr-1 þ inflammatory monocytes and/or higher proportion of Gr-1 À non-inflammatory monocytes in the sublingual tissue correlates with induction of broad Ab responses consisting of both serum IgG and SIgA responses, is in agreement with the recent report that neutrophils also control the spread of T-cell responses to distant lymph nodes. 41 The Gr-1 À monocytes, also described as tissue resident myeloid cells, have been classified as alternatively activated macrophages (M2 macrophages) capable of producing IL-10 and TGF-b. 26, 42 Interestingly, these two cytokines are central for Ig class switch in B cells and for production of IgA.
Experiments using IKKb DMye mice provided new insights into signaling for the induction of SIgA responses. Previous studies have shown that the NF-kB pathway can mediate both pro-and anti-inflammatory effects. 13, 14 Our data suggest that activation of IKKb-NF-kB signaling in myeloid cells may in fact reduce their capacity to help B cells undergo Ig class switch for production of IgA. This finding is interesting in light of the recent report that the kinase TBK1 in B cells limits IgA class switch by negative regulation of the non-canonical NF-kB pathway. 16 Thus, stimulation of non-canonical NF-kB signaling either directly in B cells or in other antigen-presenting cells could represent a major pathway for induction of IgA Abs. In this regard, we have recently shown that IKKb deficiency in intestinal epithelial cells increases IgA responses induced by CT used as an oral adjuvant. 30 The notion that IKKb can reduce or suppress the functions of macrophages or DCs is consistent with previous studies by others, suggesting that IKKb may suppress activation of M1 macrophages during infections through inhibition of STAT-1. 15 In those studies, deletion of IKKb in macrophages increased STAT-1 activation and promoted a shift toward the M1 phenotype, characterized by increased production of pro-inflammatory and inflammatory cytokines, i.e., IL-1b, TNF-a, IL-12 and IFN-g, and iNOS in response to IP injection of Group B streptococcus or E. coli lipopolysaccharide. 13, 15 While our studies showed enhanced antigen-specific Th1 cytokine responses in IKKb DMye mice after sublingual immunization, the most striking observation was the enhanced IL-17 response.
The IKKb
DMye mice were useful tools that helped us identify the repressive effect of neutrophils on IgA responses. Analysis of chemokine receptors expression by myeloid cell subsets in sublingual tissues revealed a broader expression of CCR2, CXCR2, and LTB4R2 on macrophages/dendritic cell and noninflammatory monocytes from IKKb DMye mice. One can speculate that this pattern of receptor expression could improve cellular responses to corresponding ligands and facilitate migration to inductive sites and support IgA responses. Previous studies have shown that injection of alum recruits neutrophils and induces the formation of nodules consistent with those of extracellular DNA traps. 43 A recent report showed that the formation of neutrophil extracellular traps requires phosphorylation of p65 NFkB. 44 However, neutrophil extracellular traps are primarily known to be involved in the killing of pathogens. 45 Furthermore, our results showing that neutrophils from both wild-type and IKKb DMye mice suppress transcription of IgA heavy chain suggest the involvement of other mechanisms, which will be addressed in future studies.
Nasal immunization with the cyclic AMP-inducing adjuvant CT 6 or E.coli heat LT-I 46 promotes Th17 responses. Here, we show that EdTx as a sublingual adjuvant promotes antigenspecific Th17 responses in spleen, and is associated with in vitro induction of IL-1b and IL-6. The hallmark cytokine produced by Th17 cells is IL-17A. 47 Unlike most Th-derived cytokines, IL-17A does not activate JAK-STAT, 10 but engages Act1 leading to activation of IKKb and downstream NF-kB, C/EBP, and AP-1, which in turn lead to expression of pro-inflammatory cytokines. 48, 49 Recently, it has been suggested that Th17 cells stimulate B-cell proliferation and Ig class switch for enhanced Ab production. 11 We have shown that higher levels of surface IgA. IL-17A was reported to act as a helper for the development of germinal centers. 50 Our results suggest that IKKb DMye cells stimulate B cells to be more responsive to IL-17A. This pathway could be one of the mechanisms that rescues the mucosal adjuvant EdTx and the induction of SIgA Abs.
The limited understanding of molecular and cellular mechanisms that regulate IgA responses has hampered the development of safe mucosal vaccines capable to promote mucosal IgA production. Using an experimental vaccine adjuvant that does not normally induce SIgA after sublingual immunization, we showed that IKKb is one of the key regulatory pathways for induction of SIgA responses by sublingual vaccines. We also showed that neutrophils negatively regulate IgA production by B cells, an effect that can be countered by Gr-1 À myeloid cells lacking a functional IKKb. Our results provide new insights for the development of sublingual vaccines that can promote both IgA at mucosal surfaces and IgG in the blood stream for optimal protection against infectious agents.
METHODS
Mice. Control C57BL/6 mice were obtained from The Jackson Laboratory (Bar Harbor, ME) or NCI-Frederick (Frederick, MD) and acclimated to our facility for at least 2 weeks before being used. IKKb DMye mice were kindly provided by Dr Karin (University of California at San Diego) and were generated by crossing LysMCre mice, expressing Cre downstream of the lysozyme promoter in myeloid-lineage cells, with IKKb f/f mice harboring a loxP-flanked IKKb gene 13, 14 Mice were bred in our facility, maintained in a pathogen-free environment and were used at 8-12 weeks of age. All experiments were performed in co-housed mice in accordance with both NIH and Institutional Animal Care and Use Committee guidelines.
Immunization and sample collection. The F1-V antigen and B. anthracis PA and edema factor were obtained from BEI Resources (Manassas, VA). Mice were immunized three times, i.e., Days 0, 7, and 14 by sublingual application of 30 ml of phosphate-buffered saline containing 50 mg of F1-V antigen alone, or 50 mg of F1-V antigen plus 15 mg EdTx, i.e., 15 mg PA and 15 mg edema factor. Blood and external secretions (fecal extracts, vaginal washes, and saliva) were collected as previously described. 24 In selected experiments, mice were injected IP with 0.5 mg of the neutrophil Ly6G-specific 1A8 monoclonal Ab (BioXCell, West Lebanon, NH) 2 days before the sublingual immunization. Neutrophils were isolated from bone marrow and blood using a 62% Percoll gradient, followed by magnetic activated cell sorting-sorting with the aid of CD11b microbeads.
Other materials and methods. Other methods were previously reported and are summarized in the Supplementary Materials. These methods include enzyme-linked immunosorbent assay, 22, 23 enzymelinked immunospot assay, 24 macrophage toxicity assay, 22, 23 in vitro cultures and flow cytometry analysis, and quantitative real-time reverse transcriptase-PCR. 22, 30 SUPPLEMENTARY MATERIAL is linked to the online version of the paper at http://www.nature.com/mi
